These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 15951021

  • 1. Abnormal ryanodine receptor function in heart failure.
    Yano M, Yamamoto T, Ikemoto N, Matsuzaki M.
    Pharmacol Ther; 2005 Sep; 107(3):377-91. PubMed ID: 15951021
    [Abstract] [Full Text] [Related]

  • 2. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure.
    Oda T, Yano M, Yamamoto T, Tokuhisa T, Okuda S, Doi M, Ohkusa T, Ikeda Y, Kobayashi S, Ikemoto N, Matsuzaki M.
    Circulation; 2005 Jun 28; 111(25):3400-10. PubMed ID: 15967847
    [Abstract] [Full Text] [Related]

  • 3. Role of ryanodine receptor as a Ca²(+) regulatory center in normal and failing hearts.
    Yano M, Yamamoto T, Kobayashi S, Matsuzaki M.
    J Cardiol; 2009 Feb 28; 53(1):1-7. PubMed ID: 19167631
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia.
    Yano M, Yamamoto T, Ikeda Y, Matsuzaki M.
    Nat Clin Pract Cardiovasc Med; 2006 Jan 28; 3(1):43-52. PubMed ID: 16391617
    [Abstract] [Full Text] [Related]

  • 5. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM.
    Circ Res; 2005 Dec 09; 97(12):1314-22. PubMed ID: 16269653
    [Abstract] [Full Text] [Related]

  • 6. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H.
    Cardiovasc Res; 2005 Aug 15; 67(3):379-87. PubMed ID: 15913575
    [Abstract] [Full Text] [Related]

  • 7. Ryanodine receptors as pharmacological targets for heart disease.
    Santonastasi M, Wehrens XH.
    Acta Pharmacol Sin; 2007 Jul 15; 28(7):937-44. PubMed ID: 17588328
    [Abstract] [Full Text] [Related]

  • 8. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ.
    J Cell Physiol; 2002 Jan 15; 190(1):1-6. PubMed ID: 11807805
    [Abstract] [Full Text] [Related]

  • 9. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes.
    Kohlhaas M, Zhang T, Seidler T, Zibrova D, Dybkova N, Steen A, Wagner S, Chen L, Brown JH, Bers DM, Maier LS.
    Circ Res; 2006 Feb 03; 98(2):235-44. PubMed ID: 16373600
    [Abstract] [Full Text] [Related]

  • 10. Ryanodine receptor-targeted anti-arrhythmic therapy.
    Wehrens XH, Lehnart SE, Marks AR.
    Ann N Y Acad Sci; 2005 Jun 03; 1047():366-75. PubMed ID: 16093511
    [Abstract] [Full Text] [Related]

  • 11. Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.
    Laver DR.
    Clin Exp Pharmacol Physiol; 2007 Sep 03; 34(9):889-96. PubMed ID: 17645636
    [Abstract] [Full Text] [Related]

  • 12. Cardiac ryanodine receptor function and regulation in heart disease.
    Lehnart SE, Wehrens XH, Kushnir A, Marks AR.
    Ann N Y Acad Sci; 2004 May 03; 1015():144-59. PubMed ID: 15201156
    [Abstract] [Full Text] [Related]

  • 13. Role of ryanodine receptor mutations in cardiac pathology: more questions than answers?
    Thomas NL, George CH, Lai FA.
    Biochem Soc Trans; 2006 Nov 03; 34(Pt 5):913-8. PubMed ID: 17052226
    [Abstract] [Full Text] [Related]

  • 14. Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure.
    Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M.
    J Am Coll Cardiol; 2007 Apr 24; 49(16):1722-32. PubMed ID: 17448375
    [Abstract] [Full Text] [Related]

  • 15. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.
    Jiang D, Wang R, Xiao B, Kong H, Hunt DJ, Choi P, Zhang L, Chen SR.
    Circ Res; 2005 Nov 25; 97(11):1173-81. PubMed ID: 16239587
    [Abstract] [Full Text] [Related]

  • 16. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
    Okuda S, Yano M, Doi M, Oda T, Tokuhisa T, Kohno M, Kobayashi S, Yamamoto T, Ohkusa T, Matsuzaki M.
    Circulation; 2004 Feb 24; 109(7):911-9. PubMed ID: 14757694
    [Abstract] [Full Text] [Related]

  • 17. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    George CH, Higgs GV, Lai FA.
    Circ Res; 2003 Sep 19; 93(6):531-40. PubMed ID: 12919952
    [Abstract] [Full Text] [Related]

  • 18. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure.
    Yano M, Okuda S, Oda T, Tokuhisa T, Tateishi H, Mochizuki M, Noma T, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M.
    Circulation; 2005 Dec 06; 112(23):3633-43. PubMed ID: 16330705
    [Abstract] [Full Text] [Related]

  • 19. The cardiac ryanodine receptor (RyR2) and its role in heart disease.
    Taur Y, Frishman WH.
    Cardiol Rev; 2005 Dec 06; 13(3):142-6. PubMed ID: 15831148
    [Abstract] [Full Text] [Related]

  • 20. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death.
    Marks AR.
    J Mol Cell Cardiol; 2001 Apr 06; 33(4):615-24. PubMed ID: 11273716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.